Related Experiment Videos
gamma-Butyrolactone effects on behavior induced by dopamine agonists
Biological Psychiatry
|September 1, 1983
Summary
gamma-Butyrolactone (GBL) inhibits dopamine-driven behaviors. While amphetamine partially reverses this effect, bicuculline only partially reverses GBL’s inhibition, suggesting GBL acts beyond GABA mechanisms.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Stereotyped behaviors are often mediated by dopamine pathways.
- Gamma-butyrolactone (GBL) is known to affect central nervous system activity.
Purpose of the Study:
- To investigate the mechanism by which gamma-butyrolactone (GBL) inhibits dopamine agonist-induced stereotyped behaviors.
- To explore the role of GABAergic neurotransmission in GBL's effects.
Main Methods:
- Administering GBL and various dopamine agonists (amphetamine, methylphenidate, apomorphine) to induce and inhibit stereotyped behaviors.
- Utilizing the GABA antagonist bicuculline to assess the involvement of GABA receptors.
Main Results:
- GBL potently inhibited stereotyped behaviors induced by both indirect and direct dopamine agonists.
- Amphetamine partially reversed the inhibitory effects of GBL in a dose-dependent manner.
- Bicuculline only partially reversed GBL's inhibition of apomorphine-induced activity.
Conclusions:
- GBL significantly inhibits dopamine-mediated stereotyped behaviors.
- GBL's mechanism of action likely involves pathways beyond solely interacting with GABA receptors.